Regulatory status & market

Advancing through EU approval.

Currently preparing a centralized Marketing Authorisation through the European Medicines Agency (EMA) Histovac GmbH is progressing to finalize the application for the innovative vaccine targeting the European market. The UK and North America are on the roadmap as subsequent geographies.

EU Pipeline

Pre-clinical development

Complete

Efficacy & safety studies

Complete

Regulatory dossier · EU authorisation

In progress

Marketing authorisation

Planned

Commercial launch

Planned

Geographic Focus

European Union

Primary · in pipeline

United Kingdom

Planned

North America

Planned

Further geographies

Under review

Patent-protected

Contact

Discuss regulatory partnerships.

Contact us regarding compliance or licensing and a principal will respond personally.

info@histovac.com

Histovac GmbH · Klosterneuburg · Austria